Pancreas cancer meets the thunder god.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23076355.
- Also identified by DOI 10.1126/scitranslmed.3004956.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A new formulation of a natural product shows remarkable activity against pancreatic ductal adenocarcinoma across a number of preclinical model systems. These findings set the stage for a clinical trial.
Medical subject headings
- Animals
- Antineoplastic Agents, Alkylating
- Antineoplastic Agents, Alkylating/therapeutic use
- Carcinoma, Pancreatic Ductal
- Carcinoma, Pancreatic Ductal/therapy
- Clinical Trials as Topic
- Diterpenes
- Diterpenes/therapeutic use
- Drug Evaluation, Preclinical
- Epoxy Compounds
- Epoxy Compounds/therapeutic use
- Humans
- Medical Oncology
- Medical Oncology/trends
- Medicine, Chinese Traditional
- Organophosphates
- Organophosphates/therapeutic use
- Pancreatic Neoplasms
- Pancreatic Neoplasms/therapy
- Phenanthrenes
- Phenanthrenes/therapeutic use
- Research Design
- Translational Research, Biomedical